Patricia D. Murphy

2.1k total citations
33 papers, 730 citations indexed

About

Patricia D. Murphy is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Patricia D. Murphy has authored 33 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 13 papers in Molecular Biology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Patricia D. Murphy's work include BRCA gene mutations in cancer (11 papers), Genetic factors in colorectal cancer (8 papers) and Genetics and Neurodevelopmental Disorders (7 papers). Patricia D. Murphy is often cited by papers focused on BRCA gene mutations in cancer (11 papers), Genetic factors in colorectal cancer (8 papers) and Genetics and Neurodevelopmental Disorders (7 papers). Patricia D. Murphy collaborates with scholars based in United States, Finland and Netherlands. Patricia D. Murphy's co-authors include Patricia A. Barr, Neil A. Holtzman, Michael S. Watson, Rachel T. Klein, Kathleen S. Hruska, Lisa R. Susswein, Megan L. Marshall, Zhixiong Xu, Kristen J. Vogel Postula and Karen Rothenberg and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Patricia D. Murphy

31 papers receiving 681 citations

Peers

Patricia D. Murphy
Lisa R. Susswein United States
JudyE. Garber United States
Julian Barwell United Kingdom
Sharon Durfy United States
M. Sagi Israel
Michael Gattas Australia
Betsy Bove United States
Shanna Gustafson United States
Patricia D. Murphy
Citations per year, relative to Patricia D. Murphy Patricia D. Murphy (= 1×) peers Gemma Llort

Countries citing papers authored by Patricia D. Murphy

Since Specialization
Citations

This map shows the geographic impact of Patricia D. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia D. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia D. Murphy more than expected).

Fields of papers citing papers by Patricia D. Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia D. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia D. Murphy. The network helps show where Patricia D. Murphy may publish in the future.

Co-authorship network of co-authors of Patricia D. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia D. Murphy. A scholar is included among the top collaborators of Patricia D. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia D. Murphy. Patricia D. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marshall, Megan L., Maegan E. Roberts, Lisa R. Susswein, et al.. (2020). Differences in cancer prevalence among CHEK2 carriers identified via multi-gene panel testing. Cancer Genetics. 246-247. 12–17. 25 indexed citations
2.
Mester, Jessica L., Sarah A. Jackson, Kristen J. Vogel Postula, et al.. (2019). Apparently Heterozygous TP53 Pathogenic Variants May Be Blood Limited in Patients Undergoing Hereditary Cancer Panel Testing. Journal of Molecular Diagnostics. 22(3). 396–404. 18 indexed citations
3.
Susswein, Lisa R., Megan L. Marshall, Maegan E. Roberts, et al.. (2018). Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis. Annals of Surgical Oncology. 25(12). 3556–3562. 6 indexed citations
4.
Carter, Natalie J., Megan L. Marshall, Lisa R. Susswein, et al.. (2018). Germline pathogenic variants identified in women with ovarian tumors. Gynecologic Oncology. 151(3). 481–488. 40 indexed citations
5.
Susswein, Lisa R., Megan L. Marshall, Rachel Nusbaum, et al.. (2015). Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing. Genetics in Medicine. 18(8). 823–832. 199 indexed citations
6.
Murphy, Patricia D.. (2002). Quality Assurance and Quality Control in Diagnostic Molecular Biology. Current Protocols in Human Genetics. 34(1). Unit 9.2–Unit 9.2. 1 indexed citations
7.
Murphy, Patricia D., Gloria M. Petersen, Stephen N. Thibodeau, & Richard Fishel. (2000). Genetics testing for colon cancer: Joint statement of the American College of Medical Genetics and American Society of Human Genetics: Joint Test and Technology Transfer Committee Working Group. Genetics in Medicine. 2(6). 362–366. 22 indexed citations
8.
Murphy, Patricia D., et al.. (1997). The Oncormed Approach to Genetic Testing. Genetic Testing. 1(2). 137–144. 5 indexed citations
9.
Lynch, Henry T., Hans F. A. Vasen, Jennifer Cavalieri, et al.. (1996). Genetic counseling in a navajo hereditary nonpolyposis colorectal cancer kindred. Cancer. 77(1). 30–35. 23 indexed citations
10.
Morris, James E., et al.. (1993). Molecular Confirmation of α1-Antitrypsin Genotypes in Newborn Dried Blood Specimens. Biochemical Medicine and Metabolic Biology. 50(2). 233–240. 22 indexed citations
11.
Murphy, Patricia D., Patrick L. Wilmot, & Lawrence R. Shapiro. (1992). Prenatal diagnosis of fragile X syndrome: Results from parallel molecular and cytogenetic studies. American Journal of Medical Genetics. 43(1-2). 181–186. 2 indexed citations
12.
Murphy, Patricia D., M. Watson, Lawrence R. Shapiro, Patrick L. Wilmot, & W. Roy Breg. (1991). DNA‐based genetic testing in fifty fragile X families. American Journal of Medical Genetics. 38(2-3). 305–310. 2 indexed citations
13.
Shapiro, Lawrence R., Patrick L. Wilmot, & Patricia D. Murphy. (1991). Prenatal diagnosis of the fragile X syndrome: Possible end of the experimental phase for amniotic fluid. American Journal of Medical Genetics. 38(2-3). 453–455. 6 indexed citations
14.
Shapiro, Lawrence R., Patrick L. Wilmot, Patricia D. Murphy, & W. Roy Breg. (1988). Experience with multiple approaches to the prenatal diagnosis of the fragile X syndrome: Amniotic fluid, chorionic villi, fetal blood and molecular methods. American Journal of Medical Genetics. 30(1-2). 347–354. 15 indexed citations
15.
Murphy, Patricia D., P F Lin, F.H. Ruddle, & K.K. Kidd. (1987). A second useful polymorphism for the cytosolic thymidine kinase gene (TK1) with the enzyme BstEII which will allow haplotying at this locus on chromosome 17 (q21-q22). Nucleic Acids Research. 15(17). 7212–7212. 2 indexed citations
16.
Murphy, Patricia D., et al.. (1987). A moderately frequent RFLP identified by both SacI and BanII with a probe from the HOX2 locus in man (17q11–17q22). Nucleic Acids Research. 15(15). 6311–6311. 7 indexed citations
17.
Murphy, Patricia D., J.R. Kidd, Carmela M. Castiglione, et al.. (1986). A frequent polymorphism for the cytosolic thymidine kinase gene, TK1, (17q21-q22) detected by the enzyme Taql. Nucleic Acids Research. 14(10). 4381–4381. 8 indexed citations
18.
Murphy, Patricia D., Carol Miller, & F.H. Ruddle. (1985). Quantitation of the transgenome size in chromosome-mediated gene transfer lines. Cytogenetic and Genome Research. 39(2). 125–133. 8 indexed citations
19.
Murphy, Patricia D.. (1973). Modules for Consumer Education: A Spiral-Process Approach to Curriculum Development.. 2 indexed citations
20.
Murphy, Patricia D.. (1956). Expectant Mothers Organize for Natural Childbirth. AJN American Journal of Nursing. 56(10). 1298–1301. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026